Application of dihydroartemisinin in preparation of medicine for treating inflammation caused by virulence protein of streptococcus suis
A technology of dihydroartemisinin and Streptococcus suis, applied in the field of pharmacy
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment
[0031] animal
[0032] 6-week-old female C57BL / 6 mice were raised in an experimental animal room with a constant temperature of 22°C and no specific pathogens, with a 12-hour light / dark cycle per day, free access to food and water, and an adaptation period of 2 weeks. The weight of the mice was about 25g at the beginning of the experiment . The mouse feed was maintenance feed, which was purchased from Beijing Huafukang Biotechnology Co., Ltd., and the drinking water was purified water. One week before the start of the experiment, the mice were randomly divided into 10 groups according to body weight, namely the control group, the MRP treatment group, the DhA treatment group, and the DhA+MRP treatment group. Cage three. For 6 consecutive days after the start of the test, 0.1 mL of olive oil dissolved in DhA was injected intraperitoneally into the DhA treatment group and the DhA+MRP treatment group (so that the DhA injection amount was 5 mg / kg·BW), and 0.1 mL of olive oil was ...
PUM
Property | Measurement | Unit |
---|---|---|
thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
![application no application](https://static-eureka.patsnap.com/ssr/23.2.0/_nuxt/application.06fe782c.png)
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com